Dr. Dawson, Professor of Medicine, Lombardi Cancer Center, Georgetown University Hospital, on how to decide between the various combinations of immuno-oncology (I-O) and TKIs available and indicated for the treatment of 1st line renal cell carcinoma (RCC)
0 Comments